Newsletter Issue 2, 2021 by EFSUMB

EFSUMB Newsletter

European Federation of Societies for Ultrasound in Medicine and Biology

Congress postponed to 25–28 May 2022 Timișoara, Romania WFUMB 2022, 25–28 of May, Timișoara, Romania The year 2021 started in an optimistic tone, with the hope of stopping the pandemic, in the context of starting the vaccination process, and respectively with the hope of returning to normal life. However, many of the scientific and educational activities will continue in the online environment, with the inherent advantages and disadvantages of these forms of communication. For the entire Ultrasound community, 2021 was to be a very important year, in terms of organizing the most important world scientific event of ultrasonography, namely the World Congress of Ultrasonography, in conjunction with two other major ultrasound events: The XXXIII Congress of the European Federation of Ultrasonography Societies in Medicine and Biology – EFSUMB – EUROSON and the XXIV National Conference of the Romanian Society of Ultrasonography in Medicine and Biology in Romania. Unfortunately, although the preparations continue in a straight line for this event, the epidemiological context both in Romania and in the world, does not allow us to physically organize this prestigious event this year and we had to postpone the congress for 2022. Thus, Timișoara will become for 4 days the Capital of World Ultrasonography during the WFUMB 2022, between May 25–28, 2022. The meeting will benefit of a new venue, the new Timișoara Convention Center, located in the center of the city. As your hosts we will try to surprise you with a rich and interesting scientific program but also with the Romanian hospitality, and offer

215

EFSUMB Newsletter

you the experience of our nice city, Timișoara. More detailed information can be found on the website of the event www. wfumb2022.com. We would like to renew our invitation to participate in large numbers at the most

important ultrasound meeting in 2022 – WFUMB 2022, May 25–28 Timișoara, Romania. Don’t forget to join the online EFSUMB Young Investigators‘ Session on Saturday 29 May 2021 at 10.00 CEST. We have 7 In-

vestigators competing for the 3000 euro prize. This will be followed by the EFSUMB Board of Delegates‘ Meeting at 12.00 CEST and the General Assembly with elections for the EFSUMB committees at 14.00 CEST and is open to all members.

EFSUMB Schools

216

EFSUMB CEUS Liver Webinars CHAIR: Paul Sidhu. SPEAKER: Christoph F Dietrich The role of CEUS in diagnosis and patient management of primary liver cancer (HCC). Bern, Switzerland

SPEAKER: Mikael Sawatzki. The role of CEUS in diagnosis and patient management of liver metastases. St. Gallen, Switzerland

SPEAKER: Eddie Leen. The role of CEUS for planning, guidance, monitoring and follow-up of focal ablation therapies in liver cancer. London, UK

Mikael Sawatzki Christoph F Dietrich

Learning objectives ▪ The patient at risk ▪ Screening recommendations ▪ CEUS criteria of malignancy in liver cirrhosis ▪ How to perform CEUS ▪ Liver Imaging Reporting and Data System (LI-RADS), CEUS, CECT, CEMRI ▪ The frequency (and signs) of benign FLL in liver cirrhosis ▪ Treatment options

Eddie Leen

Liver metastases are the most common malignant liver lesions in a non-cirrhotic liver. On abdominal ultrasound, liver metastases may present as hypoechoic, isoechoic or hyperechoic liver lesions, and differentiation from benign lesions (e. g., hyperechoic hemangiomas versus liver metastases) is not always possible. Contrast-enhanced ultrasound (CEUS) has a high diagnostic accuracy in the detection and differentiation of focal liver lesions. CEUS has also been shown to detect liver metastases missed by CT. Learning objectives include: ▪ CEUS criteria of malignancy ▪ Examples of CEUS in various types of liver metastases ▪ Current study results of CEUS for the detection of colorectal liver metastases ▪ Recommendation of which patient groups may benefit from additional CEUS

Learn about new application of ultrasound in guided interventional procedures: liver malignancy biopsy, primary and secondary liver malignancy ablation. Understand consolidated and new indications to ultrasound-guided interventional procedures: PEI, RFA, MWA, IRE. Appreciate the advantages and disadvantages of ultrasound-guided interventional procedures from consolidated to new applications: analysis of data from personal experiences and literature series comparison and discussion. Become familiar with the new techniques of ultrasound guidance and with the new diagnostic and therapeutic indications for ultrasound-guided interventional procedures: CEUS imaging, fusion imaging, elastosonographic imaging for liver malignancy biopsy and treatment, MWA, IRE, combination treatment.

Thursday 20 May 2021 17.00 CEST Find the webinar registration link on the EFSUMB website

217